Investigational Therapy in Mantle Cell Lymphoma: KTE-X19 CAR T-Cell Therapy

Michael Wang, MD, reacts to recent data and the potential to treat patients with relapsed or refractory mantle cell lymphoma with KTE-X19, an investigational CAR T-cell therapy.

EP. 1: Risk Stratification of Mantle Cell Lymphoma

August 24th 2020

EP. 2: Novel Therapies for Mantle Cell Lymphoma

August 24th 2020

EP. 3: KTE-X19 Treatment for R/R Mantle Cell Lymphoma

August 24th 2020

EP. 4: Implications of ZUMA-2 in R/R Mantle Cell Lymphoma

August 24th 2020

EP. 5: KTE-X19 for R/R MCL: Treatment Considerations

August 24th 2020

EP. 6: MRD Assessment in Mantle Cell Lymphoma

August 24th 2020

EP. 7: Limitations in Treating R/R Mantle Cell Lymphoma

August 24th 2020